FDA and EMA approve Novartis’ treatment for follicular lymphoma patients
October 27, 2021Research and Development
The FDA and EMA have accepted Novartis’ Supplemental Biologics License Application (sBLA) and Type II Variation for KymriahⓇ in patients …
NIHR funds COVID-19 antiviral trial
October 26, 2021Manufacturing and Production
The National Institute for Health research has awarded funding to the University of Oxford, working with several other UK universities, …
CHMP begins rolling review of COVID oral antiviral
October 26, 2021Manufacturing and Production
The EMA’s human medicine’s committee (CHMP) has initiated a rolling review of the investigational antiviral drug molnupiravir for the treatment …
Hospitals and pharmacies facing medicine shortages, says The London Economic
October 26, 2021Manufacturing and Production
As the NHS faces soaring waiting lists and prepares for a winter surge in COVID cases, they must also gear …
MHRA licenses uterine fibroid treatment for women in Great Britain
October 26, 2021Manufacturing and Production
The MHRA has granted a licence for Ryeqo (a relugolix combination therapy), for the treatment of moderate to severe symptoms …
Infectious disease expert says children between 5-11 could be vaccinated in November
October 25, 2021Sales and Marketing
Infectious disease expert, Dr Anthony Fauci, has said that COVID-19 vaccines for children aged 5-11 could be available by early …
More people self-funding routine operations as NHS waiting lists hit record levels
October 25, 2021Sales and Marketing
New data from the Private Healthcare Information Network (PHIN) reveals that people are increasingly opting to self-fund private treatment. This …
Novartis Phase III study into canakinumab does not meet primary endpoint
October 25, 2021Sales and Marketing
Novartis have announced that their CANOPY-1 Phase III study, which evaluated the efficacy of canakinumab, did not meet its primary …
AstraZeneca biliary cancer drug shows improved survival rate in patients
October 25, 2021Sales and Marketing
AstraZeneca has announced that its Imfinzi drug, for the treatment of biliary tract cancer, has improved overall survival in patients …
Companion test for lung cancer approved by FDA
October 22, 2021Medical Communications
The US FDA has approved of the Roche VENTANA PD-L1 Assay as a companion diagnostic for Tecentriq® in non-small cell …
Servier Phase III colorectal cancer trial fails to meet primary endpoint
October 22, 2021Medical Communications
Global independent pharmaceutical group, Servier, has announced that the primary objective (progression free survival) of the Phase III SOLSTICE trial …
CDC approves the mixing of COVID shots
October 22, 2021Medical Communications
The US Centers for Disease Control and Prevention (CDC) has backed a plan to allow COVID-19 vaccine boosters for recipients …
Xtrava Health Receives Emergency Use Authorisation for COVID-19 Ag Test
October 22, 2021Medical Communications
The US FDA has issued an Emergency Use Authorisation (EUA) for Xtrava’s SPERAâ„¢ COVID-19 Ag Test. The easy-to-use, rapid lateral …
‘Plan C’ COVID response is urgent, doctors say
October 21, 2021Business Services
UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals …
Open Orphan to conduct first-ever COVID-19 human challenge trial
October 21, 2021Business Services
Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study. The company has signed …
Novartis extend COVID-19 vaccine deal with BioNTech
October 21, 2021Business Services
Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish …
Small Pharma’s Phase IIa DMT-assisted therapy begins
October 21, 2021Business Services
Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its …
IXICO partner with Microsoft to enhance AI platform
October 20, 2021Research and Development
IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …
Synairgen COVID-19 treatment moves to Phase III trials
October 20, 2021Research and Development
Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …
Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit
October 20, 2021Research and Development
Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …
Latest content
